MIRA INFORM REPORT

 

 

Report Date :           

29.06.2011

 

IDENTIFICATION DETAILS

 

Name :

TRISMED CO., LTD

 

 

 

 

Registered Office :

1359, Gwanpyeong-dong, Yuseong-gu, Daejeon, Korea, Rm. 409, Hansin SMECA, Zip Code 305-509

 

 

 

 

Country :

South Korea

 

 

 

 

Financials (as on) :

31.12.2008

 

 

 

 

Date of Incorporation :

15.12.2000

 

 

 

 

Com. Reg. No.:

314-81-38103

 

 

 

 

Legal Form :

Co., Ltd by Shares

 

 

 

 

Line of Business :

Manufacture of Electro-Diagnostic and Therapy Apparatuses

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear


NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2011

 

Country Name

Previous Rating

                   (31.12.2010)                  

Current Rating

(31.03.2011)

South korea

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 Bottom of Form

 

Basic

 

Company Name

TRISMED CO., LTD.

(Korean Company Name : “()트리스메드”)

Registered Address

1359, Gwanpyeong-dong, Yuseong-gu, Daejeon, Korea

Building

Rm. 409, Hansin SMECA

Zip Code

305-509

Tel

+82-42-936-7201

Fax

+82-42-936-7202

E-mail

trismed@kornet.net

Website

www.trismed.com

Trading Address

Rm. 409, Hansin SMECA, 1359, Gwanpyeong-dong, Yuseong-gu, Daejeon, Korea

Tel

+82-42-936-7201

Fax

+82-42-936-7202

Type

Export/Import

Industry

Manufacture of Electro-Diagnostic and Therapy Apparatuses

  Main Business

Electrocardiograph, Cardiac Diagnosis Systems

Established (mm/dd/yyyy)

12/15/2000

 

 

Detailed Products

 

Activity

Detailed Products (UNSPSC)

Sell

Electrocardiography EKG units(42181701)

 

 

CEO’s

 

Name

Lee Hoon-Kyeu

Address

Suite 302, 1011, Gwanpyeong-dong, Yuseong-gu, Daejeon, Korea

Date of Birth

08/10/1955

Title

President & CEO

Sex

Male

Nationality

Korean

 

 

Profiles

 

Capital (KRW)

430,000,000

Employees

10

Formation

Co., Ltd by Shares

Venture Business

Bank Details

Industrial Bank of Korea-Daejeon Branch

Hana Bank

Corporate Registered No.

160111-0109002

Business Registered No.

314-81-38103

Permit & Licenses

08/27/2003 ISO 9001 by TUV

 

Int’l Trade No.: 16105801

Shareholder Position

N/A

Company History

12/15/2000 Incorporated as the present name

06/08/2002 Increased capital to 430,00,000 KRW from 315,000,000 KRW

03/22/2004 Designated as a Venture Business

01/2007 Designated as an INNO-BIZ Company

05/13/2008 Moved to the present HQ address from 548-1, Yongsan-dong, Yuseong-gu, Daejeon, Korea

03/22/2010 Designated as a Venture Business again

 

 

 

 

Management

 

Job Description

Title

Name

Sex

Nationality

Inauguration Date

President & CEO

Mr.

Lee Hoon-Kyeu

Male

Korean

03/24/2009

Director

Mr.

Lee Keun-Hong

Male

Korean

03/24/2009

Auditor

M/S.

Baik Jin-Hee

Female

Korean

03/31/2003

 

 

Financials

 

Year / Unit : KRW

Sales

Assets

Net Income

2010

 

 

 

2009

 

 

 

2008

1,230,000,000

1,752,000,000

403,000,000

2007

1,181,000,000

1,576,000,000

261,000,000

2006

1,375,000,000

1,161,000,000

-

2005

1,265,000,000

 

 

2004

119,000,000

 

 

2003

680,000,000

 

 

The latest financials are not available, and the Subject Company does not have any obligations to release its financials to the public.

 

 

Financial Description

 

Authorized Capital(KRW)

1,260,000,000

Paid-Up Capital(KRW)

430,000,000

Total Issues Shares

86,000

 


 

Balance Sheet

 

Unit : Korean Won

As of 12/31/2008

As of 12/31/2007

As of 12/31/2006

Total Assets

1,752,000,000

1,576,000,000

1,161,000,000

Current Assets

846,000,000

1,281,000,000

 

-Quick Assets

805,000,000

1,235,000,000

 

-Inventories

41,000,000

45,000,000

 

Fixed Assets

906,000,000

296,000,000

 

-Investment

50,000,000

38,000,000

 

-Tangibles

512,000,000

26,000,000

 

-Intangibles

344,000,000

187,000,000

 

Total Liabilities

81,000,000

309,000,000

154,000,000

Current Liabilities

45,000,000

309,000,000

 

Fixed Liabilities

36,000,000

-

 

Capital Stock

430,000,000

430,000,000

 

Capital Surplus

-

-

 

Profit Surplus

1,242,000,000

838,000,000

 

Capital Adjustment

-

-

 

Total Equity

1,671,000,000

1,267,000,000

1,007,000,000

Liab. & Shareholder’s Equity

1,752,000,000

1,576,000,000

1,161,000,000

 

 

Income Statement

 

Unit : Korean Won

As of 12/31/2008

As of 12/31/2007

As of 12/31/2006

Sales

1,230,000,000

1,181,000,000

1,375,000,000

Cost of Sold Goods

578,000,000

656,000,000

 

Gross Profit

652,000,000

525,000,000

 

Selling & Admin. Expenses

539,000,000

380,000,000

 

Operating Income

113,000,000

145,000,000

 

Non-Operating Income

350,000,000

173,000,000

 

Non-Operating Expenses

60,000,000

20,000,000

 

Income Before Taxes

403,000,000

297,000,000

 

Income Taxes Expenses

-

37,000,000

 

Net Income

403,000,000

261,000,000

-

 

 

Cash Flows

 

Unit : Korean Won

As of 12/31/2008

As of 12/31/2007

As of 12/31/2006

Cash Flows from Operating

 

 

 

-Net Income

 

 

 

-Exp. without Cash Outflow

 

 

 

-Revenue without Cash Inflows

 

 

 

-Changes in Asset/ & Liability

 

 

 

Cash Flows from Investing

 

 

 

-Cash Inflow from Investing

 

 

 

-Cash Outflows for Investing

 

 

 

Cash Flows from Financing

 

 

 

-Cash Inflows from Financing

 

 

 

-Cash Outflows from Financing

 

 

 

Increase/Decrease in Cash

 

 

 

Cash at the Beginning of Year

 

 

 

Cash at the End of Year

 

 

 

 

 

Products, Technologies, Services Description

 

Main Products & Services

Electrocardiograph, Cardiac Diagnosis Systems

 

 

Trade Partners & Competitors

 

Competitors

DONGBANG HEALTHDYNE CO., LTD.

3RD FL., UNICON BLDG., 140-17, SAMSEONG 2-DONG, GANGNAM-GU, SEOUL, KOREA

TEL:+82-2-566-9966  FAX:+82-2-566-9963

 

PATIENT MONITOR

YONGHYEON INDUSTRIAL COMPLEX, 522-6, YONGHYEON-DONG, UIJEONGBU-SI, GYEONGGI-DO, KOREA

TEL:+82-31-853-1522  FAX:+82-31-853-1525

 

MGB ENDOSCOPY CO., LTD.

RM. 1101, E&C VENTURE DREAM TOWER 3-CHA, 197-33, GURO 3-DONG, GURO-GU, SEOUL, KOREA

TEL:+82-70-7585-6444  FAX:+82-2-6300-6417

 

 

Sales by Region

(Activity & Markets)

 

The Subject deals with the companies in Asia, Europe and Africa.

Court Action

 

Not Available.

 

 

News Clipping

 

----


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.05

UK Pound

1

Rs.71.92

Euro

1

Rs.64.37

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.